Keywords: Novo Nordisk, Oxford University, Research collaboation, Rheumatoid arthritis, Inflammatory diseases

Novo Nordisk collaborates with Oxford University on RA and other inflammatory diseases research

Article | 25 April 2012

Print This

Departing from its core competence, diabetes, Danish insulin giant Novo Nordisk (NOV: N) and the Kennedy Institute of Rheumatology at ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in